Destination Europe:Research and Innovation OpportunitiesGitte Neubauer, Founder and VP Research Operations, Cellzome
A European career: the academic partVocational training Work A-levels Work in UK Start of Undergraduate Studies in Biochem...
A European career: the industry part                › Addition of skill sets for drug                                     ...
Industry or academia - family or career? –Take the best of all worlds!›   Many moves from academia to industry and back:  ...
Upcoming SlideShare
Loading in …5
×

Gitte neubauer

546 views

Published on

Published in: Technology, Business
0 Comments
0 Likes
Statistics
Notes
  • Be the first to comment

  • Be the first to like this

No Downloads
Views
Total views
546
On SlideShare
0
From Embeds
0
Number of Embeds
24
Actions
Shares
0
Downloads
4
Comments
0
Likes
0
Embeds 0
No embeds

No notes for slide

Gitte neubauer

  1. 1. Destination Europe:Research and Innovation OpportunitiesGitte Neubauer, Founder and VP Research Operations, Cellzome
  2. 2. A European career: the academic partVocational training Work A-levels Work in UK Start of Undergraduate Studies in Biochemistry PhD in ProteomicsImperial College, London (Natural Sciences)>1,200 staff / 3,000 undergraduates /1,200 postgraduate studentsnatural sciences embedded with medical faculty and hospitals / translation of researchEuropean Molecular Biology Laboratory, Heidelberg, Germany>1,500 staff / >70 nationalities / 4 outstationsEMBL ranks no. 4 world-wide (after CSH, MIT, Salk) institute in molecular biology & genetics*>2000 collaborations world-wide Located in Heidelberg, an international city in the middle of *1999-2009, Thomson Essential Science Indicators Europe 2
  3. 3. A European career: the industry part › Addition of skill sets for drug 2002 Nature 2000 › Foundationwhile retaining 2000 discovery of Cellzome in 2004 Nat Cell Bio › Started as proteomics platform › International culture 2006 Nature and is now a drug discovery › High quality company 2007 Nat Biotech › Open, respectful, collaborrative › World-leading chemoproteomics 2007 culture platform Nat Biotech 2009 › Financing through early venture Nature capital and since 2004 through 2011 Nat Biotech collaborations with big pharma 2011 2011 Nature 3
  4. 4. Industry or academia - family or career? –Take the best of all worlds!› Many moves from academia to industry and back: › 9 Cellzomers are now professors/groupleaders in academia› Many moves from biotech to pharma: › 10 people moved to big pharma› Women careers: family or career? › Higher availability of day care facilities for small kids and (even in Germany) more all day schools › First men take time off with their kids – perception is changing › Technology allows work from home more effectively › Not the case for lab-based positions › But: still few women in pharma or biotech senior management 4

×